From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approve new daily pill for common skin cancer

from Medical News Today

Taken in the form of a daily pill, Odomzo is marketed by Novartis AG — a Swiss pharma giant with U.S. headquarters in East Hanover, New Jersey. The U.S. Food and Drug Administration say a trial showed the drug shrank or wiped out tumors in 58 percent of patients treated. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063